114 related articles for article (PubMed ID: 21744696)
1. The determinants of B-type natriuretic peptide release in acute, non-ST-segment elevation myocardial infarction.
Vorlat A; Claeys MJ; Snoep L; Haine S; Miljoen H; Bosmans J; Vrints CJ
Acta Cardiol; 2011 Jun; 66(3):281-5. PubMed ID: 21744696
[TBL] [Abstract][Full Text] [Related]
2. Association of elevated B-type natriuretic peptide levels with angiographic findings among patients with unstable angina and non-ST-segment elevation myocardial infarction.
Sadanandan S; Cannon CP; Chekuri K; Murphy SA; Dibattiste PM; Morrow DA; de Lemos JA; Braunwald E; Gibson CM
J Am Coll Cardiol; 2004 Aug; 44(3):564-8. PubMed ID: 15358021
[TBL] [Abstract][Full Text] [Related]
3. Relation of plasma brain natriuretic peptide levels in non-ST-elevation coronary disease and preserved systolic function to number of narrowed coronary arteries.
Palazzuoli A; Gennari L; Calabria P; Quatrini I; Vecchiato L; De Paola V; Campagna MS; Palazzuoli V; Nuti R
Am J Cardiol; 2005 Dec; 96(12):1705-10. PubMed ID: 16360361
[TBL] [Abstract][Full Text] [Related]
4. Plasma and pericardial fluid natriuretic peptide levels in postinfarction ventricular dysfunction.
Klemola R; Tikkanen I; Vuolteenaho O; Toivonen L; Laine M
Eur J Heart Fail; 2001 Jan; 3(1):21-6. PubMed ID: 11163731
[TBL] [Abstract][Full Text] [Related]
5. Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Haeck JD; Verouden NJ; Kuijt WJ; Koch KT; Van Straalen JP; Fischer J; Groenink M; Bilodeau L; Tijssen JG; Krucoff MW; De Winter RJ
Am J Cardiol; 2010 Apr; 105(8):1065-9. PubMed ID: 20381654
[TBL] [Abstract][Full Text] [Related]
6. B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction: an ENTIRE-TIMI-23 substudy.
Mega JL; Morrow DA; De Lemos JA; Sabatine MS; Murphy SA; Rifai N; Gibson CM; Antman EM; Braunwald E
J Am Coll Cardiol; 2004 Jul; 44(2):335-9. PubMed ID: 15261928
[TBL] [Abstract][Full Text] [Related]
7. B-type natriuretic peptide as an independent predictor of coronary disease extension in non-ST elevation coronary syndromes with preserved systolic function.
Palazzuoli A; Caputo M; Fineschi M; Navarri R; Calabrò A; Cameli M; Campagna MS; Franci B; Pierli C; Nuti R; Maisel A
Eur J Prev Cardiol; 2012 Jun; 19(3):366-73. PubMed ID: 21464097
[TBL] [Abstract][Full Text] [Related]
8. B-type natriuretic peptide levels predict extent and severity of coronary disease in non-ST elevation coronary syndromes and normal left ventricular systolic function.
Palazzuoli A; Maisel A; Caputo M; Fineschi M; Quatrini I; Calabrò A; Campagna MS; Franci B; Grothgar S; Pierli C; Nuti R
Regul Pept; 2011 Feb; 167(1):129-33. PubMed ID: 21237213
[TBL] [Abstract][Full Text] [Related]
9. Occurrence and predictors of left ventricular systolic dysfunction at hospital discharge and in long-term follow-up after acute myocardial infarction treated with primary percutaneous coronary intervention.
Świątkiewicz I; Magielski P; Woźnicki M; Gierach J; Jabłoński M; Fabiszak T; Koziński M; Sukiennik A; Bronisz A; Kubica J
Kardiol Pol; 2012; 70(4):329-40. PubMed ID: 22528703
[TBL] [Abstract][Full Text] [Related]
10. Value of brain natriuretic peptide after acute myocardial infarction.
Güneş Y; Okçün B; Kavlak E; Erbaş C; Karcier S
Anadolu Kardiyol Derg; 2008 Jun; 8(3):182-7. PubMed ID: 18524723
[TBL] [Abstract][Full Text] [Related]
11. B-type natriuretic peptide and assessment of jeopardised myocardium in acute myocardial infarction.
Vorlat A; Claeys MJ; Bosmans JM; Van Hoof V; Vrints CJ
Int J Cardiol; 2007 Jan; 114(1):46-9. PubMed ID: 16644042
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the usefulness of Doppler-derived deceleration time versus plasma brain natriuretic peptide to predict left ventricular remodeling after mechanical revascularization in patients with ST-elevation acute myocardial infarction and left ventricular systolic dysfunction.
Cerisano G; Pucci PD; Valenti R; Boddi V; Migliorini A; Tommasi MS; Raspanti S; Parodi G; Antoniucci D
Am J Cardiol; 2005 Apr; 95(8):930-4. PubMed ID: 15820157
[TBL] [Abstract][Full Text] [Related]
13. B-type natriuretic peptide levels predict extent and severity of coronary artery disease in non-ST elevation acute coronary syndrome and normal left ventricular function.
Goyal BM; Sharma SM; Walia M
Indian Heart J; 2014; 66(2):183-7. PubMed ID: 24814112
[TBL] [Abstract][Full Text] [Related]
14. Brain natriuretic peptide and other risk markers for outcome assessment in patients with non-ST-elevation coronary syndromes and preserved systolic function.
Palazzuoli A; Deckers J; Calabrò A; Campagna MS; Nuti R; Pastorelli M; Pasqui AL; Bruni F; Auteri A; Puccetti L
Am J Cardiol; 2006 Nov; 98(10):1322-8. PubMed ID: 17134622
[TBL] [Abstract][Full Text] [Related]
15. Changes in B-type natriuretic peptides after surgical ventricular restoration.
Sartipy U; Albåge A; Larsson PT; Insulander P; Lindblom D
Eur J Cardiothorac Surg; 2007 May; 31(5):922-8. PubMed ID: 17321144
[TBL] [Abstract][Full Text] [Related]
16. Relationship of left atrial global peak systolic strain with left ventricular diastolic dysfunction and brain natriuretic peptide level in patients presenting with non-ST elevation myocardial infarction.
Değirmenci H; Bakırcı EM; Demirtaş L; Duman H; Hamur H; Ceyhun G; Topal E
Med Sci Monit; 2014 Oct; 20():2013-9. PubMed ID: 25338184
[TBL] [Abstract][Full Text] [Related]
17. Relative role of NT-pro BNP and cardiac troponin T at 96 hours for estimation of infarct size and left ventricular function after acute myocardial infarction.
Steen H; Futterer S; Merten C; Jünger C; Katus HA; Giannitsis E
J Cardiovasc Magn Reson; 2007; 9(5):749-58. PubMed ID: 17891611
[TBL] [Abstract][Full Text] [Related]
18. Biphasic and monophasic pattern of brain natriuretic peptide release in acute myocardial infarction.
Dilić M; Nalbantić AD; Arslanagić A; Huskić J; Brdjanović S; Kulić M; Hodzić E; Sokolović S; Zvizdić F; Dzubur A
Coll Antropol; 2011 Mar; 35(1):155-9. PubMed ID: 21667539
[TBL] [Abstract][Full Text] [Related]
19. Predicting chronic left ventricular dysfunction 90 days after ST-segment elevation myocardial infarction: An Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) Substudy.
Ezekowitz JA; Armstrong PW; Granger CB; Theroux P; Stebbins A; Kim RJ; Patel MR
Am Heart J; 2010 Aug; 160(2):272-8. PubMed ID: 20691832
[TBL] [Abstract][Full Text] [Related]
20. B-type natriuretic peptide as an integrated risk marker in non-ST elevation acute coronary syndromes.
Yamamoto T; Sato N; Yasutake M; Takagi H; Morita N; Akutsu K; Fujii M; Fujita N; Tanaka K; Takano T
Int J Cardiol; 2006 Aug; 111(2):224-30. PubMed ID: 16185779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
